Patents by Inventor Michael Stephen Roberts

Michael Stephen Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220212783
    Abstract: A multimode clutch assembly is positioned in a powertrain of a rotorcraft. The clutch assembly includes a freewheeling unit having a driving mode in which torque applied to the input race is transferred to the output race and an overrunning mode in which torque applied to the output race is not transferred to the input race. A bypass assembly has an engaged position that couples the input and output races of the freewheeling unit. An actuator assembly shifts the bypass assembly between engaged and disengaged positions. An engagement status sensor is configured to determine the engagement status of the bypass assembly. In the disengaged position, the overrunning mode of the freewheeling unit is enabled such that the clutch assembly is configured for unidirectional torque transfer. In the engaged position, the overrunning mode of the freewheeling unit is disabled such that the clutch assembly is configured for bidirectional torque transfer.
    Type: Application
    Filed: November 1, 2021
    Publication date: July 7, 2022
    Applicant: Textron Innovations Inc.
    Inventors: Douglas Andrew Goodwin, David Andrew Prater, Eric Stephen Olson, David Bryan Roberts, Chia-Wei Su, Michael David Trantham, Charles Eric Covington
  • Publication number: 20200000707
    Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Inventors: Michael Stephen Roberts, Mantu Sarkar, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Gregory Davey
  • Patent number: 9757455
    Abstract: The present invention provides an oral delivery system for a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof with pharmacological, physiological or biochemical activity. The present invention particularly provides a swallow formulation comprising a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof which facilitates the rapid delivery of the therapeutic compound to the circulatory system.
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: September 12, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Michael Stephen Roberts, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Greg Davey, Mantu Sarkar
  • Publication number: 20130065885
    Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 14, 2013
    Applicant: IMAGINOT PTY LTD.
    Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Andrew Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
  • Patent number: 8216610
    Abstract: The present invention relates generally to formulations comprising paracetamol. More particularly, the present invention provides a swallow formulation comprising paracetamol which facilitates the rapid delivery of paracetamol into the circulatory system following oral administration. The present invention further relates to methods for inducing efficient pain relief including an analgesic effect by the administration of the paracetamol formulation.
    Type: Grant
    Filed: November 27, 2006
    Date of Patent: July 10, 2012
    Assignee: Imaginot Pty Ltd.
    Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Andrew Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
  • Publication number: 20090311327
    Abstract: The present, invention provides an oral delivery system for a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof with pharmacological, physiological or biochemical activity. The present invention particularly provides a swallow formulation comprising a therapeutic compound that is an acid, a salt of an acid or an unionized compound or a proactive form thereof which facilitates the rapid delivery of the therapeutic compound to the circulatory system.
    Type: Application
    Filed: November 28, 2006
    Publication date: December 17, 2009
    Applicant: IMAGINOT PTY LTD
    Inventors: Michael Stephen Roberts, George Alexander Davidson, Ruoying Jiang, Geraldine Ann Elliott, Keivan Bezanehtak, Stephen Douglas Chandler, Greg Davey, Mantu Sarkar
  • Publication number: 20080287456
    Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.
    Type: Application
    Filed: May 27, 2005
    Publication date: November 20, 2008
    Applicant: IMAGINOT PTY LTD
    Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar
  • Patent number: 6909012
    Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: June 21, 2005
    Assignee: University of Queensland
    Inventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
  • Publication number: 20030220497
    Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.
    Type: Application
    Filed: December 27, 2002
    Publication date: November 27, 2003
    Applicant: The University of Queensland
    Inventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
  • Patent number: 6593365
    Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: July 15, 2003
    Assignee: The University of Queensland
    Inventors: Daniel Yung-Yu Hung, Michael Stephen Roberts
  • Patent number: 6001088
    Abstract: An iontophoresis method for delivenng an active substance or drug to a target tissue which includes the step of sandwiching the target tissue between a donor electrode and receptor electrode which are each electrically connnected to a power source wherein a current path between the donor electrode and the receptor electrode is maintained at a minimum value to enhance delivery of the active substance to the target tissue.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: December 14, 1999
    Assignee: The University of Queensland
    Inventors: Michael Stephen Roberts, Sheree Elizabeth Cross, Pam Muhtze Lai, Lawrence William Hirst
  • Patent number: 5820302
    Abstract: A method of stabilizing soil and aggregate for structural purposes including the step of mixing with water: (a) a soil aggregate base material; (b) a stabilization composition comprising: (i) an alkali metal silicate or other suitable gel precursor, and (ii) optionally a cation; and (c) a minimum amount of 1% of cement based on the weight of the resulting mixture, whereby sufficient water is added to the resulting mixture to hydrate the cement and thereby provide a stabilized soil aggregate matrix suitable for use in a structure.
    Type: Grant
    Filed: October 21, 1996
    Date of Patent: October 13, 1998
    Assignee: AD-Base Pty Ltd.
    Inventors: Michael Stephen Roberts, Peter Atkinson, Nicholas James Calos, David Lethbridge Oliver
  • Patent number: 5750141
    Abstract: A vaso-active agent is administered in combination with a therapeutic agent which is useful in treatment of tissue of the body which is located below the stratum corneum or the outermost layer of the epidermis, wherein the vaso-active agent may be administered by a local, topical or transdermal route to a particular site and the therapeutic agent may be administered in a similar manner in combination with the vaso-active agent or may be administered separately, wherein the vaso-active agent and the therapeutic agent for topical and/or transdermal administration may be provided in the form of a composition so as to increase local perfusion and/or concentration of the therapeutic agent at or adjacent an administration site of the vaso-active agent.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: May 12, 1998
    Assignee: The University of Queensland
    Inventors: Michael Stephen Roberts, Sheree Elizabeth Cross, Parminder Singh